z-logo
open-access-imgOpen Access
Nanopharmaceutical May Offer Benefits in Combinations
Publication year - 2013
Publication title -
cancer discovery
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.795
H-Index - 163
eISSN - 2159-8290
pISSN - 2159-8274
DOI - 10.1158/2159-8290.cd-nb2013-155
Subject(s) - bevacizumab , medicine , kidney cancer , oncology , angiogenesis , cancer , pharmacology , cancer research , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom